The Russian Ministry of Health has allowed clinical trials of the Sputnik V vaccine with a modified composition. This comes from registries, reports of approved clinical trials. RIA News.
The registration states that the aim of the study is to evaluate the safety, reactogenicity and immunogenicity of the vector vaccine in adult volunteers for the prevention of COVID-19 caused by the “SARS-CoV-2 Gam-COVID-Vac virus” with a modified antigenic profile.”
The research is expected to end on December 31, 2024, with 100 volunteers participating.
The Ministry of Health also authorized the conduct of clinical trials of an updated vaccine against coronavirus infection for adolescents aged 12 to 17 years. They will end at the same time.
Deputy Head of the Ministry of Health Tatyana Semenova in the summer reportedHe said that in the fall, Russians will be able to be vaccinated with updated vaccines of the NF Gamaleya Center, including vaccines against new types of coronavirus.
Previous scientists I learnedHe said the measles vaccine protects girls from autism.